Bukwang Pharmaceutical IND

부광약품KRX: 003000· Fiscal year 2025· bukwang.co.kr ↗

Average salary
$47.1K
₩62.7M
▼ 3.4% vs 2024
Employees
650
▲ 11.7% vs 2024
Average tenure
10.3 yrs

Estimated take-home of this pay:$3.2K / monthCalculate →

Workplace

Women's pay (men = 100)65
Women among staff33.5%
Contract staff4.6%

Recent official filings

Quick read

  • Average pay is 3% above the median of the companies we track.
  • Average pay fell 3.4% from 2024.
  • Headcount grew by 68 (11.7%) from 2024.
  • Ranks #83 of 238 Healthcare & Pharma companies in this country by pay.
  • Revenue grew 25.4% year over year.
  • Revenue has grown two years in a row.
  • Operating margin was 7.1% in 2025.
  • Operating loss of $28.1M in 2023.

Last 3 years

Revenue
$94.5M2023$120.2M2024$150.7M2025
Operating income
-$28.1M2023$1.2M2024$10.6M2025

See the share price on Naver Finance ↗

Investor metrics

2025
Revenue per employee
$231.2K
Net profit per employee
$14.3K
Operating margin
7.1%
Net margin
6.2%
ROE
3.6%
Debt-to-equity
39.7%
Equity ratio
71.6%
Payout ratio
99.2%
Dividend per share
$0
Dividend yield (as disclosed)
3.3%

Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.

Similar companies

USD at ₩1,332.22 per $1 (2026-11-19, ExchangeRate-API)

Source: DART (Financial Supervisory Service, Korea)

Not investment advice. Figures come from public filings and may contain errors.